Immunization with recombinant duffy binding-like-γ3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate a-binding plasmodium falciparum parasites
Journal of Infectious Diseases, Volume 188, No. 1, Year 2003
Notification
URL copied to clipboard!
Maternal malaria is associated with the sequestration, in the placenta, of Plasmodium falciparum-infected erythrocytes onto chondroitin sulfate A (CSA), via the duffy binding-like (DBL)-γ3 domain of the P. falciparum erythrocyte membrane protein 1 (PfEMP1CSA) (DBL-γ3CSA). The production of antibodies against CSA-binding infected erythrocytes (IEsCSA) is correlated with resistance to maternal malaria in multiparous women. We produced recombinant DBL-γ3CSA (rDBL-γ3CSA) in insect cells, corresponding to 2 variant DBL-γ3CSA subtypes that mediate binding to CSA in laboratory lines and placental isolates. Both recombinant cysteine-rich DBL-γ3CSA domains blocked IEsCSA binding to CSA. Immunization of mice, with the rDBL-γ3CSA-FCR3 and rDBL-γ3CSA-3D7 domains, resulted in the generation of antibodies recognizing homologous and heterologous rDBL-γ3CSA, a finding indicating conserved epitopes inducing a pan-reactive immune response. Mouse monoclonal antibodies (MAbs) against both recombinant proteins were pan-reactive with various IEsCSA. One MAb efficiently inhibited and reversed IECSA cytoadhesion to endothelial cells in vitro. Thus, DBL-γ3CSA is the target of inhibitory and pan-reactive antibodies. Saimiri sciureus monkeys immunized with FCR3-rDBL-γ3CSA developed pan-reactive and inhibitory antibodies, a finding suggesting that the development of a vaccine to prevent maternal malaria is feasible.